Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Aditxt, Inc. to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25th-27th, 2022

January 14, 2022 GMT

RICHMOND, Va.--(BUSINESS WIRE)--Jan 14, 2022--

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX) announced today it is participating in Edison Group’s Open House Event, scheduled to take place virtually this month.

The three-day event, in association with the London Stock Exchange, global law firm Taylor Wessing, and OpenExchange, will take place between January 25 th -27 th, focusing on 33 companies. Day one will feature businesses within pharmaceuticals & drug discovery, day two focuses on AI & technology in healthcare, while businesses adopting new approaches to hard-to-solve problems will round off the event.

Content will be available to stream from January 25 th on Edison’s website and Attendance is free and anyone wanting to attend can sign up here:


For more information on the event and details on how to register, please see below.

Edison Group:
Global Healthcare Open House Conference 2022
Date: January 25 th -27 th, 2022
Edison Group Open House Registration

Presentation information: The company presentation will be available on demand on beginning at 7am ET on Wednesday, January 26 th. The presentation will also be available on the Company’s investor relations page.

1x1 Meeting Registration: To register for a 1x1 meeting with the Company, please visit this link.


For any questions about the event or how to register, please reach out to

About Aditxt™

Aditxt develops technologies focused on improving immune system health through immune monitoring and reprogramming. Aditxt’s immune monitoring technology is designed to provide a personalized, comprehensive system immune system profile. Aditxt’s immune reprogramming technology, currently preclinical, is designed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies. AditxtScore™ for COVID-19 is Aditxt’s proprietary immune profile technology to equip people with information about their level of protection. For more information, please visit: and

About Edison Group:

Edison’s leading research and investor relations consultancy connects listed companies to the widest pool of global investors. By focusing on both the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors, Edison can create and gauge intent to purchase, even in the darkest pools of capital.

View source version on

CONTACT: Media and Investor Relations Contact:

Edison Investment Research



SOURCE: Aditxt, Inc.

Copyright Business Wire 2022.

PUB: 01/14/2022 09:00 AM/DISC: 01/14/2022 09:02 AM